Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons

Treatment of degenerating basal forebrain cholinergic neurons with nerve growth factor (NGF) in Alzheimer’s disease has long been contemplated, but an effective and safe delivery method has been lacking. Towards achieving this goal, we are currently developing CERE-110, an adeno-associated virus-bas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bishop, Kathie M., Hofer, Eva K., Mehta, Arpesh, Ramirez, Anthony, Sun, Liangwu, Tuszynski, Mark, Bartus, Raymond T.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2709503/
https://ncbi.nlm.nih.gov/pubmed/18439998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2008.03.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars